US Toning Down China CDMO Tension But New Restrictions Emerge
New Executive Order On Table
The latest developments in a US Congressional draft bill to curb Chinese biotech operations in the US is separating contract manufacturing and research from gene sequencing service providers, which may give China's major contract players reasons to breathe easy.
